Anesthesia for liver transplantation: The experience of the University of Bologna in the MELD era

Minerva Gastroenterologica e Dietologica

Volumn 56, Issue 3, 2010, Pages 253-260

  Siniscalchi, A ^a   Miklosova, Z ^a   Spedicato, S ^a   Bernardi, E ^a   Zanoni, A ^a   Dante, A ^a   Pierucci, E ^a   Cimatti, M ^a   Riganello, I ^a   Aurini, L ^a   Bernabe L ^a   Faenza, S ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Liver cirrhosis; Liver transplantation; Postoperative period, complications

Indexed keywords

ACUTE KIDNEY FAILURE; ADULT; ANESTHESIA; DISEASE SEVERITY; ENDOTRACHEAL INTUBATION; FEMALE; HEMODYNAMIC PARAMETERS; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SYSTEM; MORBIDITY; MORTALITY; POSTOPERATIVE COMPLICATION; REVIEW; SCORING SYSTEM; SURVIVAL TIME;

ANESTHESIA; END STAGE LIVER DISEASE; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 79251527528     PISSN: 00264776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1990;334:693-9.
2. Yao FY, Xiao L, Bass NM, Kerlan R, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging. Am J Transplant 2007;7:2587-96. (Pubitemid 47561609)
3. Duffy JP, Varadanian A, Benjamin E, Watson M, Farmer DG, Ghobrial RM et al. Liver transplantation criteria for hepatocellular carcinoma should be expanded:a 22-year experience with 467 patients at UCLA. Ann Surg 2007;246:502-9. (Pubitemid 47312148)
4. Onaca N, Davis GL, Goldstein RM, Jennings LW, Klintmalm GB. Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation. Liver Transpl 2007; 13:391-6.
5. Iwakiri Y, Groszmann RJ. The hyperdynamic circulation of chronic liver disease: from the patient to the molecule. Hepatology 2006;43:S121-131-5.
6. Bellentani S, Saccoccio G, Costa G, Tiribelli C, Manenti F, Sodde M et al. Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group. Gut 1997;41:845-50.
7. Dindo D, Demartines N, Clavien PA. Classification of Surgical Complications. A New Proposal With Evaluation in a Cohort of 6336 Patients and Result of a Survey. Annals of Surgery 2004;240:205-13.
8. Ploeg RJ, D'Alessandro AM, Knechtle SJ, Stegall MD, Pirsch JD, Hoffmann RM et al. Risk factors for primary dysfunction after liver transplantation:a multivariate analysis. Transplantation 1993;55:807-13.
9. Maring JK, Klompmaker IJ, Zwaveling JH, Kranenburg K, Ten Vergert EM, Slooff MJ. Poor initial graft function after orthtotopic liver transplantation:can it be predicted and does it affect outcome? An analysis of 125 adult primary transplantations. Clinical Transplantation 1997;11:373-9.
10. Gonzalez FX, Rimola A, Grande L, Antolin M, Garcia-Valdecasas JC, Fuster J et al. Predictive factors of early post-operative graft function in human liver transplantation. Hepatology 1994;20:565-73. (Pubitemid 24271262)
11. Snover DC, Freese DK, Sharp HL, Bloomer JR, Najarian JS, Ascher NL. Liver allograft rejection. An analysis of the use of biopsy in determining outcome of rejection. Am J Surg Pathol 1987;11:1-10.
12. Blei AT, Mazhar S, Davidson CJ, Flamm SL, Abecassis M, Gheorghiade M. Hemodynamic evaluation before liver transplantation. J Clin Gastroenterol 2007;41: S323-329.
13. Onaca NN, Levy MF, Netto GJ, Thomas MJ, Sanchez EQ, Chinnakotla S et al. Pretransplant MELD score as a predictor of outcome after liver transplantation for chronic hepatitis C. Am J Transplant 2003;3:626-30.
14. Saab S, Wang V, Ibrahim AB, Durazo F, Han S, Farmer DG et al. MELD score predicts 1-year patient survival post-orthotopic liver transplantation. Liver Transplantation 2003;9:473-6.
15. Riyami DA, Alam A, Badovinac K, Ivis F, Trpeski L, Cantarovich M. Decreased survival in liver transplant patients requiring chronic dialysis: a Canadian experience. Transplantation 2008;85:1277-80. (Pubitemid 351670476)
16. Sanchez EQ, Gonwa TA, Levy MF, Goldstein RM, Mai ML, Hays SR et al. Preoperative and perioperative predictors of the need for renal replacement therapy after orthotopic liver transplantation. Transplantation 2004;78:1048-54.
17. Cabezuelo JB, Ramírez P, Ríos A, Acosta F, Torres D, Sansano T et al. Risk factors of acute renal failure after liver transplantation. Kidney International 2006;69: 1073-80.
18. Angeli P, Merkel C. Pathogenesis and management of hepatorenal syndrome in patients with cirrhosis. Journal of Hepatology 2008;48:S93-103.
19. Turban S, Thuluvath PJ, Atta MG. Hepatorenal syndrome. World J Gastroenterol 2007;13:4046-55.
20. Colle I, Durand F, Pessione F, Rassiat E, Bernuau J, Barrière E et al. Clinical corse, predictive factors and prognosis in patients with cirrhosis and type 1 hepatorenal sindrome treated with terlipressin: A retrospective analysis. Journal of Gastroenterology and Hepatology 2002;17:882-8.
21. Restuccia T, Ortega R, Guevara M, Ginès P, Alessandria C, Ozdogan O et al. Effects of treatment of hepatorenal sindrome before transplantation on posttransplantation outcome. A case-control study. Journal of Hepatology 2004;40:140-6.
22. Kenchappa RS, Diwakar L, Boyd MR, Ravindranath V. Thioltransferase (glutaredoxin) mediates recovery of motor neurons from excitotoxic mitochondrial injury. J Neuroscience 2002;22:8402-10.
23. Di Martini A, Fontes P, Dew MA, Lotrich FE, de Vera M. Age, model for end-stage liver disease score, and organ functioning predict posttransplant tacrolimus neurotoxicity. Liver Transpl 2008;14:815-22.